ESCRS Clinical Survey 2016 Results
The 2016 ESCRS Survey was performed at the XXXIV Congress of the ESCRS in Copenhagen, Denmark. Delegates also had the option to take the survey via an electronic version at and following the ESCRS Congress.
More than 1,879 delegates responded to this survey, which included 202 questions. Survey questions were developed and reviewed with the ESCRS leadership team, and substantiated by a data scientist. ESCRS delegates were surveyed on 11 different clinical areas including: general cataract surgery, laser assisted cataract surgery, astigmatism management, presbyopia correction, ocular surface diseases, corneal refractive surgery, and others.
The ESCRS leadership will regularly review the results of these annual surveys and this feedback will help us to better identify education needs of the delegates. This data will also help expand the quantity and quality of education opportunities at the Annual Congress of the ESCRS, the ESCRS Winter Meeting, and multiple other education channels like EuroTimes articles and online forums.
Download Supplement - click here
Latest Articles
Glaucoma Treatment Under Pressure
New techniques and technologies add to surgeons’ difficult decisions
Outside the Box, Inside the Pipeline
Researchers are tackling glaucoma diagnosis and treatment from all sides.
The EHDS Is Ready for the Green Light
If proposal is approved, Europe could see better access to, and exchange and use of, health data.
ESCRS to Release Guidelines for Cataract and Refractive Surgery
Comprehensive approach to the safest and most effective modern surgery.
Barry Fellowship Opens Up ‘Whole New Field of Thought’
The 2022 recipient combines theoretical and practical to learn new treatments.
Digitalising the OR—Experience and Perspectives
Benefits include saving time and improving outcomes.
Dynamic Measures Needed for Quality of Vision
Functional visual acuity testing and straylight metering may better reflect real-world conditions.
What Is Stopping Digital OR Adoption?
Ophthalmologists know the benefits—now it’s time to construct the right plan.
Time to Move Beyond Monofocal IOLs?
European surgeons appear hesitant to first offer other presbyopia-correcting options to patients.